Cargando…
Risk of myocarditis and pericarditis after a COVID-19 mRNA vaccine booster and after COVID-19 in those with and without prior SARS-CoV-2 infection: A self-controlled case series analysis in England
BACKGROUND: An increased risk of myocarditis or pericarditis after priming with mRNA Coronavirus Disease 2019 (COVID-19) vaccines has been shown but information on the risk post-booster is limited. With the now high prevalence of prior Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) inf...
Autores principales: | Stowe, Julia, Miller, Elizabeth, Andrews, Nick, Whitaker, Heather J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10286992/ https://www.ncbi.nlm.nih.gov/pubmed/37285378 http://dx.doi.org/10.1371/journal.pmed.1004245 |
Ejemplares similares
-
Myocarditis and pericarditis after vaccination for COVID‐19
por: Hudson, Blake, et al.
Publicado: (2021) -
Myocarditis and pericarditis after COVID-19 vaccination
Publicado: (2021) -
Low rate of myocarditis/pericarditis after COVID-19 mRNA vaccines
Publicado: (2022) -
COVID-19 mRNA vaccination and myocarditis or pericarditis
por: Husby, Anders, et al.
Publicado: (2022) -
Myocarditis, pericarditis, and COVID-19 mRNA-vaccination
por: Sookaromdee, Pathum, et al.
Publicado: (2022)